Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.68257712 |
2 | negative regulation of cell killing (GO:0031342) | 5.68257712 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.29687546 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.98209356 |
5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.98209356 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.95819644 |
7 | negative thymic T cell selection (GO:0045060) | 4.71455747 |
8 | response to peptidoglycan (GO:0032494) | 4.65970065 |
9 | NIK/NF-kappaB signaling (GO:0038061) | 4.65188429 |
10 | negative T cell selection (GO:0043383) | 4.57588300 |
11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.31292294 |
12 | detection of other organism (GO:0098543) | 4.20837261 |
13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.18166436 |
14 | detection of bacterium (GO:0016045) | 4.17163666 |
15 | thymic T cell selection (GO:0045061) | 4.13302523 |
16 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.10073375 |
17 | positive thymic T cell selection (GO:0045059) | 4.08076238 |
18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.02928501 |
19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.92029107 |
20 | leukocyte aggregation (GO:0070486) | 3.88944088 |
21 | T cell selection (GO:0045058) | 3.81780659 |
22 | response to host immune response (GO:0052572) | 3.61947047 |
23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.61947047 |
24 | B cell receptor signaling pathway (GO:0050853) | 3.57419494 |
25 | response to interleukin-15 (GO:0070672) | 3.51719671 |
26 | response to host (GO:0075136) | 3.48393606 |
27 | response to host defenses (GO:0052200) | 3.48393606 |
28 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.48393606 |
29 | regulation of mast cell degranulation (GO:0043304) | 3.45696674 |
30 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.44501029 |
31 | detection of external biotic stimulus (GO:0098581) | 3.43805520 |
32 | positive T cell selection (GO:0043368) | 3.38368747 |
33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.33166012 |
34 | regulation of T cell tolerance induction (GO:0002664) | 3.33046840 |
35 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.32559424 |
36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.31558226 |
37 | defense response to protozoan (GO:0042832) | 3.27847687 |
38 | regulation of leukocyte degranulation (GO:0043300) | 3.27826365 |
39 | T cell migration (GO:0072678) | 3.26234586 |
40 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.25222105 |
41 | cellular response to type I interferon (GO:0071357) | 3.24944090 |
42 | regulation of B cell differentiation (GO:0045577) | 3.24759465 |
43 | mannose metabolic process (GO:0006013) | 3.21673521 |
44 | natural killer cell differentiation (GO:0001779) | 3.18204363 |
45 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.15123518 |
46 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.14060138 |
47 | cellular response to interleukin-15 (GO:0071350) | 3.14020372 |
48 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.13329519 |
49 | negative regulation of T cell mediated immunity (GO:0002710) | 3.13248536 |
50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.11129084 |
51 | response to muramyl dipeptide (GO:0032495) | 3.10039575 |
52 | respiratory burst (GO:0045730) | 3.09547963 |
53 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08411670 |
54 | response to protozoan (GO:0001562) | 3.08102915 |
55 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.05024095 |
56 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.04071175 |
57 | myeloid dendritic cell differentiation (GO:0043011) | 3.02263243 |
58 | detection of biotic stimulus (GO:0009595) | 3.01237097 |
59 | negative regulation of phagocytosis (GO:0050765) | 2.99220468 |
60 | detection of molecule of bacterial origin (GO:0032490) | 2.95391739 |
61 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.93514221 |
62 | positive regulation of B cell differentiation (GO:0045579) | 2.93456412 |
63 | negative regulation of interleukin-6 production (GO:0032715) | 2.92863647 |
64 | myeloid dendritic cell activation (GO:0001773) | 2.92693497 |
65 | mature B cell differentiation (GO:0002335) | 2.92539193 |
66 | neutrophil activation (GO:0042119) | 2.91860243 |
67 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91493852 |
68 | positive regulation of lamellipodium assembly (GO:0010592) | 2.88606230 |
69 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.88133763 |
70 | interferon-gamma production (GO:0032609) | 2.87036681 |
71 | neutrophil activation involved in immune response (GO:0002283) | 2.86519169 |
72 | leukocyte cell-cell adhesion (GO:0007159) | 2.84450559 |
73 | macrophage activation (GO:0042116) | 2.84009224 |
74 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.83134251 |
75 | positive regulation of type 2 immune response (GO:0002830) | 2.82358411 |
76 | tolerance induction (GO:0002507) | 2.82071241 |
77 | positive regulation of mast cell activation (GO:0033005) | 2.81971132 |
78 | B cell mediated immunity (GO:0019724) | 2.79281603 |
79 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.79224004 |
80 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.78978062 |
81 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.78697569 |
82 | leukocyte degranulation (GO:0043299) | 2.78661192 |
83 | T cell costimulation (GO:0031295) | 2.78020330 |
84 | regulation of regulated secretory pathway (GO:1903305) | 2.77624979 |
85 | positive regulation of histone deacetylation (GO:0031065) | 2.77495259 |
86 | regulation of mast cell activation (GO:0033003) | 2.77295931 |
87 | negative regulation of innate immune response (GO:0045824) | 2.76447414 |
88 | granulocyte activation (GO:0036230) | 2.76184372 |
89 | negative regulation of type 2 immune response (GO:0002829) | 2.74912107 |
90 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.74336970 |
91 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.73558404 |
92 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.73558404 |
93 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.73558404 |
94 | T cell receptor signaling pathway (GO:0050852) | 2.73289788 |
95 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.72981374 |
96 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.72341335 |
97 | regulation of type 2 immune response (GO:0002828) | 2.72240967 |
98 | positive regulation of lamellipodium organization (GO:1902745) | 2.71551805 |
99 | immunoglobulin mediated immune response (GO:0016064) | 2.71106322 |
100 | lymphocyte costimulation (GO:0031294) | 2.71009151 |
101 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.70439026 |
102 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.69966365 |
103 | actin nucleation (GO:0045010) | 2.69603393 |
104 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.68836287 |
105 | positive regulation of interleukin-2 production (GO:0032743) | 2.68200477 |
106 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.65526683 |
107 | positive regulation of antigen processing and presentation (GO:0002579) | 2.65280454 |
108 | neutrophil mediated immunity (GO:0002446) | 2.65203623 |
109 | dendritic cell differentiation (GO:0097028) | 2.64770408 |
110 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.64290701 |
111 | positive regulation by symbiont of host defense response (GO:0052509) | 2.64165993 |
112 | modulation by symbiont of host defense response (GO:0052031) | 2.64165993 |
113 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.64165993 |
114 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.64165993 |
115 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.64165993 |
116 | modulation by symbiont of host immune response (GO:0052553) | 2.64165993 |
117 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.63544107 |
118 | microglial cell activation (GO:0001774) | 2.63142818 |
119 | positive regulation of interferon-alpha production (GO:0032727) | 2.62073802 |
120 | mast cell activation (GO:0045576) | 2.61130463 |
121 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.59651723 |
122 | natural killer cell mediated immunity (GO:0002228) | 2.59651723 |
123 | signal complex assembly (GO:0007172) | 2.57790224 |
124 | negative regulation of interleukin-12 production (GO:0032695) | 2.56954889 |
125 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.56093825 |
126 | natural killer cell activation (GO:0030101) | 2.54774954 |
127 | growth hormone receptor signaling pathway (GO:0060396) | 2.53987432 |
128 | regulation of response to interferon-gamma (GO:0060330) | 2.52724217 |
129 | regulation of antigen processing and presentation (GO:0002577) | 2.52622117 |
130 | regulation of tolerance induction (GO:0002643) | 2.52131232 |
131 | lymphocyte migration (GO:0072676) | 2.50132331 |
132 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.49317181 |
133 | positive regulation of isotype switching (GO:0045830) | 2.48730471 |
134 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.48577065 |
135 | regulation of necroptotic process (GO:0060544) | 2.47624632 |
136 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.46922553 |
137 | germinal center formation (GO:0002467) | 2.45156706 |
138 | cellular extravasation (GO:0045123) | 2.44389961 |
139 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.44105201 |
140 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.44105201 |
141 | response to type I interferon (GO:0034340) | 2.43820671 |
142 | positive regulation of tolerance induction (GO:0002645) | 2.42979047 |
143 | myeloid cell activation involved in immune response (GO:0002275) | 2.42050696 |
144 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.40439050 |
145 | macrophage activation involved in immune response (GO:0002281) | 2.40150255 |
146 | T cell homeostasis (GO:0043029) | 2.39894092 |
147 | type I interferon signaling pathway (GO:0060337) | 2.39223570 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.45147660 |
2 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.96672182 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.83040863 |
4 | MYC_22102868_ChIP-Seq_BL_Human | 3.72163800 |
5 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.65449096 |
6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.58583929 |
7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.19796287 |
8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.12747221 |
9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.02526950 |
10 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.78441646 |
11 | MAF_26560356_Chip-Seq_TH1_Human | 2.64336040 |
12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.59329076 |
13 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.53966687 |
14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.53190822 |
15 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.53005018 |
16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.45387761 |
17 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.44847886 |
18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43660694 |
19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.43148056 |
20 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.39737533 |
21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.39066927 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.37828156 |
23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.35322951 |
24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33222451 |
25 | UTX_26944678_Chip-Seq_JUKART_Human | 2.31808955 |
26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.29447485 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.26510632 |
28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.19039860 |
29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.18816821 |
30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.15448061 |
31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.14024737 |
32 | MYB_26560356_Chip-Seq_TH1_Human | 2.10868134 |
33 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.10854379 |
34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.08809353 |
35 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.05648424 |
36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04434086 |
37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.02230832 |
38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89503735 |
39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87083938 |
40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84713238 |
41 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.76191610 |
42 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.72311440 |
43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71652911 |
44 | MAF_26560356_Chip-Seq_TH2_Human | 1.66917260 |
45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.64583762 |
46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63834610 |
47 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.62756894 |
48 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.51787390 |
49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.47720985 |
50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.46981997 |
51 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39974272 |
52 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.39578430 |
53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36069797 |
54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.34339249 |
55 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.32801315 |
56 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31822291 |
57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30888889 |
58 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.30814448 |
59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30697033 |
60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.30026045 |
61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29716076 |
62 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29587726 |
63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27848639 |
64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27425293 |
65 | P68_20966046_ChIP-Seq_HELA_Human | 1.26611404 |
66 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26539255 |
67 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24005536 |
68 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21717294 |
69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21620949 |
70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19499381 |
71 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18530037 |
72 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.18336905 |
73 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18336429 |
74 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17862488 |
75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16463972 |
76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15649878 |
77 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14844672 |
78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13165632 |
79 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13083517 |
80 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.12104730 |
81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11834273 |
82 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.10934140 |
83 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.09468132 |
84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09368416 |
85 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09120922 |
86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08749782 |
87 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.06043452 |
88 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05673793 |
89 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05354177 |
90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04114791 |
91 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.04073522 |
92 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03363869 |
93 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02968889 |
94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02827423 |
95 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02227315 |
96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02016496 |
97 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01940939 |
98 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01317628 |
99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00942878 |
100 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00713510 |
101 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00164907 |
102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99348514 |
103 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99172781 |
104 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97833642 |
105 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97338821 |
106 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96853900 |
107 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95726577 |
108 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95491589 |
109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95070520 |
110 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94431567 |
111 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93323208 |
112 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92703345 |
113 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.91722470 |
114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91533676 |
115 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89823775 |
116 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85637874 |
117 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.85232350 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000685_abnormal_immune_system | 3.34133350 |
2 | MP0001835_abnormal_antigen_presentation | 3.32077095 |
3 | MP0003303_peritoneal_inflammation | 3.24362602 |
4 | MP0003724_increased_susceptibility_to | 3.09190713 |
5 | MP0004510_myositis | 2.92357290 |
6 | MP0003436_decreased_susceptibility_to | 2.85249445 |
7 | MP0005387_immune_system_phenotype | 2.82136830 |
8 | MP0001790_abnormal_immune_system | 2.82136830 |
9 | MP0001800_abnormal_humoral_immune | 2.66941600 |
10 | MP0000569_abnormal_digit_pigmentation | 2.58509808 |
11 | MP0002452_abnormal_antigen_presenting | 2.44766258 |
12 | MP0005000_abnormal_immune_tolerance | 2.42237131 |
13 | MP0003763_abnormal_thymus_physiology | 2.41134635 |
14 | MP0005671_abnormal_response_to | 2.37409805 |
15 | MP0003300_gastrointestinal_ulcer | 2.35804329 |
16 | MP0002420_abnormal_adaptive_immunity | 2.33521228 |
17 | MP0001819_abnormal_immune_cell | 2.32273039 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.32264918 |
19 | MP0002396_abnormal_hematopoietic_system | 2.28531065 |
20 | MP0002166_altered_tumor_susceptibility | 2.28096352 |
21 | MP0002723_abnormal_immune_serum | 2.26904802 |
22 | MP0004808_abnormal_hematopoietic_stem | 2.25857767 |
23 | MP0002398_abnormal_bone_marrow | 2.25697125 |
24 | MP0009278_abnormal_bone_marrow | 2.20823914 |
25 | MP0010352_gastrointestinal_tract_polyps | 2.15244633 |
26 | MP0008260_abnormal_autophagy | 2.12849103 |
27 | MP0002419_abnormal_innate_immunity | 2.06670873 |
28 | MP0001348_abnormal_lacrimal_gland | 1.98469798 |
29 | MP0000716_abnormal_immune_system | 1.97465709 |
30 | MP0009785_altered_susceptibility_to | 1.97278008 |
31 | MP0005025_abnormal_response_to | 1.96538955 |
32 | MP0002405_respiratory_system_inflammati | 1.95744011 |
33 | MP0003705_abnormal_hypodermis_morpholog | 1.94028248 |
34 | MP0005076_abnormal_cell_differentiation | 1.90808969 |
35 | MP0004947_skin_inflammation | 1.85985338 |
36 | MP0005397_hematopoietic_system_phenotyp | 1.84492554 |
37 | MP0001545_abnormal_hematopoietic_system | 1.84492554 |
38 | MP0002006_tumorigenesis | 1.84438376 |
39 | MP0001873_stomach_inflammation | 1.80404678 |
40 | MP0005451_abnormal_body_composition | 1.78630835 |
41 | MP0003566_abnormal_cell_adhesion | 1.78248542 |
42 | MP0005464_abnormal_platelet_physiology | 1.77112627 |
43 | MP0002148_abnormal_hypersensitivity_rea | 1.76986519 |
44 | MP0003172_abnormal_lysosome_physiology | 1.73405242 |
45 | MP0002722_abnormal_immune_system | 1.72370404 |
46 | MP0000703_abnormal_thymus_morphology | 1.72211729 |
47 | MP0000689_abnormal_spleen_morphology | 1.72142999 |
48 | MP0002429_abnormal_blood_cell | 1.62537739 |
49 | * MP0003091_abnormal_cell_migration | 1.62400662 |
50 | MP0008961_abnormal_basal_metabolism | 1.59278957 |
51 | MP0009333_abnormal_splenocyte_physiolog | 1.54871656 |
52 | MP0005310_abnormal_salivary_gland | 1.51618953 |
53 | MP0010155_abnormal_intestine_physiology | 1.51107102 |
54 | MP0003279_aneurysm | 1.47186616 |
55 | MP0000858_altered_metastatic_potential | 1.47071059 |
56 | MP0001853_heart_inflammation | 1.43443982 |
57 | MP0004859_abnormal_synaptic_plasticity | 1.37806331 |
58 | MP0001533_abnormal_skeleton_physiology | 1.37240445 |
59 | MP0003183_abnormal_peptide_metabolism | 1.37056557 |
60 | MP0009764_decreased_sensitivity_to | 1.35314772 |
61 | MP0003448_altered_tumor_morphology | 1.32849128 |
62 | MP0001845_abnormal_inflammatory_respons | 1.31447423 |
63 | MP0006082_CNS_inflammation | 1.29400979 |
64 | MP0005023_abnormal_wound_healing | 1.28386681 |
65 | MP0005058_abnormal_lysosome_morphology | 1.25402786 |
66 | MP0002933_joint_inflammation | 1.25401324 |
67 | MP0002877_abnormal_melanocyte_morpholog | 1.24965696 |
68 | MP0003045_fibrosis | 1.19977334 |
69 | MP0003866_abnormal_defecation | 1.15329623 |
70 | MP0005174_abnormal_tail_pigmentation | 1.15229253 |
71 | MP0001958_emphysema | 1.13484924 |
72 | MP0002138_abnormal_hepatobiliary_system | 1.13090992 |
73 | MP0010307_abnormal_tumor_latency | 1.11106557 |
74 | MP0008438_abnormal_cutaneous_collagen | 1.08654203 |
75 | MP0000733_abnormal_muscle_development | 1.07778248 |
76 | MP0004381_abnormal_hair_follicle | 1.06645714 |
77 | MP0008004_abnormal_stomach_pH | 1.02564748 |
78 | MP0002132_abnormal_respiratory_system | 1.02243525 |
79 | MP0000490_abnormal_crypts_of | 1.00198369 |
80 | MP0003690_abnormal_glial_cell | 0.97313947 |
81 | MP0002998_abnormal_bone_remodeling | 0.95909598 |
82 | MP0004883_abnormal_blood_vessel | 0.92132251 |
83 | MP0008874_decreased_physiological_sensi | 0.90676251 |
84 | MP0000465_gastrointestinal_hemorrhage | 0.90017253 |
85 | MP0009840_abnormal_foam_cell | 0.89581281 |
86 | MP0003075_altered_response_to | 0.87138564 |
87 | MP0001851_eye_inflammation | 0.86739266 |
88 | MP0002019_abnormal_tumor_incidence | 0.85932242 |
89 | MP0000678_abnormal_parathyroid_gland | 0.81350886 |
90 | MP0002254_reproductive_system_inflammat | 0.80357627 |
91 | * MP0005621_abnormal_cell_physiology | 0.79282092 |
92 | MP0005164_abnormal_response_to | 0.79013631 |
93 | MP0000343_altered_response_to | 0.78101607 |
94 | MP0004858_abnormal_nervous_system | 0.78019789 |
95 | MP0000767_abnormal_smooth_muscle | 0.76823368 |
96 | MP0005623_abnormal_meninges_morphology | 0.75247168 |
97 | MP0008469_abnormal_protein_level | 0.74197437 |
98 | MP0009765_abnormal_xenobiotic_induced | 0.74026184 |
99 | MP0010234_abnormal_vibrissa_follicle | 0.73862125 |
100 | MP0005390_skeleton_phenotype | 0.73151078 |
101 | MP0003453_abnormal_keratinocyte_physiol | 0.70644477 |
102 | MP0009763_increased_sensitivity_to | 0.65761000 |
103 | MP0001243_abnormal_dermal_layer | 0.65321575 |
104 | MP0002928_abnormal_bile_duct | 0.64553801 |
105 | MP0001663_abnormal_digestive_system | 0.64111336 |
106 | MP0000681_abnormal_thyroid_gland | 0.63939878 |
107 | MP0003329_amyloid_beta_deposits | 0.63236490 |
108 | MP0001849_ear_inflammation | 0.62605320 |
109 | MP0000604_amyloidosis | 0.61456078 |
110 | MP0002163_abnormal_gland_morphology | 0.59499067 |
111 | MP0005409_darkened_coat_color | 0.58919035 |
112 | MP0000350_abnormal_cell_proliferation | 0.58254650 |
113 | MP0008770_decreased_survivor_rate | 0.57830313 |
114 | MP0004185_abnormal_adipocyte_glucose | 0.56022531 |
115 | MP0003795_abnormal_bone_structure | 0.54739158 |
116 | MP0001915_intracranial_hemorrhage | 0.54487761 |
117 | MP0000249_abnormal_blood_vessel | 0.54306807 |
118 | MP0003828_pulmonary_edema | 0.54084536 |
119 | MP0005166_decreased_susceptibility_to | 0.52842789 |
120 | MP0006054_spinal_hemorrhage | 0.52557050 |
121 | MP0000015_abnormal_ear_pigmentation | 0.52401502 |
122 | MP0000371_diluted_coat_color | 0.52303165 |
123 | MP0005666_abnormal_adipose_tissue | 0.51499580 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 3.61201583 |
2 | Eczematoid dermatitis (HP:0000976) | 3.61031031 |
3 | Recurrent fungal infections (HP:0002841) | 3.48729387 |
4 | Recurrent viral infections (HP:0004429) | 3.39804089 |
5 | Cellulitis (HP:0100658) | 3.25001439 |
6 | Recurrent bacterial skin infections (HP:0005406) | 3.21650718 |
7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.13812906 |
8 | Chronic otitis media (HP:0000389) | 3.10653349 |
9 | Gastrointestinal infarctions (HP:0005244) | 3.09704553 |
10 | Nasal polyposis (HP:0100582) | 3.09021566 |
11 | Myositis (HP:0100614) | 3.00743767 |
12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.97076814 |
13 | Recurrent bronchitis (HP:0002837) | 2.96795078 |
14 | Cerebral aneurysm (HP:0004944) | 2.90802612 |
15 | Autoimmune thrombocytopenia (HP:0001973) | 2.86084363 |
16 | Abnormality of the fingertips (HP:0001211) | 2.79628822 |
17 | Mediastinal lymphadenopathy (HP:0100721) | 2.78484324 |
18 | Abnormality of T cell number (HP:0011839) | 2.75618639 |
19 | Encephalitis (HP:0002383) | 2.75152077 |
20 | T lymphocytopenia (HP:0005403) | 2.72099856 |
21 | Increased density of long bones (HP:0006392) | 2.71291298 |
22 | Keratoconjunctivitis sicca (HP:0001097) | 2.71157342 |
23 | Abnormality of the nasal mucosa (HP:0000433) | 2.62619691 |
24 | Gastrointestinal inflammation (HP:0004386) | 2.60619754 |
25 | Peritonitis (HP:0002586) | 2.58791577 |
26 | Epistaxis (HP:0000421) | 2.58193622 |
27 | Urticaria (HP:0001025) | 2.57638798 |
28 | Inflammation of the large intestine (HP:0002037) | 2.56923152 |
29 | Amyloidosis (HP:0011034) | 2.55649084 |
30 | Protrusio acetabuli (HP:0003179) | 2.55184342 |
31 | Papilloma (HP:0012740) | 2.54548526 |
32 | Verrucae (HP:0200043) | 2.54548526 |
33 | Panhypogammaglobulinemia (HP:0003139) | 2.49549011 |
34 | Dilatation of the ascending aorta (HP:0005111) | 2.47044119 |
35 | Increased IgE level (HP:0003212) | 2.46254739 |
36 | Thrombocytosis (HP:0001894) | 2.44248149 |
37 | Agammaglobulinemia (HP:0004432) | 2.43641148 |
38 | Colitis (HP:0002583) | 2.43511983 |
39 | Keratoconjunctivitis (HP:0001096) | 2.41366884 |
40 | Petechiae (HP:0000967) | 2.39101861 |
41 | Abnormality of glycolipid metabolism (HP:0010969) | 2.38033231 |
42 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.38033231 |
43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.38033231 |
44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.37791410 |
45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.37791410 |
46 | Episodic fever (HP:0001954) | 2.37688014 |
47 | Sepsis (HP:0100806) | 2.36440276 |
48 | IgM deficiency (HP:0002850) | 2.35030682 |
49 | Absent frontal sinuses (HP:0002688) | 2.34296433 |
50 | Periodontitis (HP:0000704) | 2.31349711 |
51 | Meningitis (HP:0001287) | 2.30683736 |
52 | Hemoptysis (HP:0002105) | 2.30269333 |
53 | Abnormality of T cells (HP:0002843) | 2.28766483 |
54 | Hyperacusis (HP:0010780) | 2.28093944 |
55 | Fatigue (HP:0012378) | 2.26399461 |
56 | Gingival bleeding (HP:0000225) | 2.25899485 |
57 | Recurrent skin infections (HP:0001581) | 2.24486864 |
58 | Chest pain (HP:0100749) | 2.24256705 |
59 | Spinal cord lesions (HP:0100561) | 2.22869728 |
60 | Syringomyelia (HP:0003396) | 2.22869728 |
61 | Aortic aneurysm (HP:0004942) | 2.22113538 |
62 | Leukocytosis (HP:0001974) | 2.21855233 |
63 | Pustule (HP:0200039) | 2.20237053 |
64 | Vasculitis (HP:0002633) | 2.17660140 |
65 | Emphysema (HP:0002097) | 2.16795338 |
66 | Orchitis (HP:0100796) | 2.13356244 |
67 | Arterial thrombosis (HP:0004420) | 2.12513256 |
68 | Loss of speech (HP:0002371) | 2.12204079 |
69 | Frequent falls (HP:0002359) | 2.11443571 |
70 | Gingivitis (HP:0000230) | 2.11118479 |
71 | Upper limb amyotrophy (HP:0009129) | 2.07843124 |
72 | Distal upper limb amyotrophy (HP:0007149) | 2.07843124 |
73 | Slow saccadic eye movements (HP:0000514) | 2.07525003 |
74 | Purpura (HP:0000979) | 2.07149615 |
75 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.06979956 |
76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.06695279 |
77 | Obstructive lung disease (HP:0006536) | 2.06695279 |
78 | Eosinophilia (HP:0001880) | 2.05173069 |
79 | Broad face (HP:0000283) | 2.04733420 |
80 | Interstitial pulmonary disease (HP:0006530) | 2.04081557 |
81 | Shallow orbits (HP:0000586) | 2.03755793 |
82 | Abnormality of macrophages (HP:0004311) | 2.02986075 |
83 | Hypertensive crisis (HP:0100735) | 2.02381931 |
84 | Increased IgM level (HP:0003496) | 2.01358826 |
85 | Genu recurvatum (HP:0002816) | 2.00283336 |
86 | Skin ulcer (HP:0200042) | 1.98826185 |
87 | Hypochromic anemia (HP:0001931) | 1.97139266 |
88 | Pulmonary infiltrates (HP:0002113) | 1.97069797 |
89 | Thyroiditis (HP:0100646) | 1.93951961 |
90 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93618862 |
91 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93618862 |
92 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93618862 |
93 | Obstructive sleep apnea (HP:0002870) | 1.93514943 |
94 | Recurrent pneumonia (HP:0006532) | 1.93491696 |
95 | Recurrent lower respiratory tract infections (HP:0002783) | 1.92091021 |
96 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.91805113 |
97 | Hematochezia (HP:0002573) | 1.90919523 |
98 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90624069 |
99 | Osteolytic defects of the hand bones (HP:0009699) | 1.90560695 |
100 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.90560695 |
101 | Polygenic inheritance (HP:0010982) | 1.90300502 |
102 | Spontaneous hematomas (HP:0007420) | 1.89662086 |
103 | Lymphopenia (HP:0001888) | 1.88752212 |
104 | Spondylolisthesis (HP:0003302) | 1.88562464 |
105 | Abnormal platelet volume (HP:0011876) | 1.88214236 |
106 | Viral hepatitis (HP:0006562) | 1.87809507 |
107 | Autoimmune hemolytic anemia (HP:0001890) | 1.87410070 |
108 | Long palpebral fissure (HP:0000637) | 1.86780410 |
109 | Mitral valve prolapse (HP:0001634) | 1.86056276 |
110 | Dysostosis multiplex (HP:0000943) | 1.84022460 |
111 | Abnormality of the pleura (HP:0002103) | 1.83974947 |
112 | Mucopolysacchariduria (HP:0008155) | 1.83956036 |
113 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83956036 |
114 | Increased cerebral lipofuscin (HP:0011813) | 1.83021423 |
115 | Hypochromic microcytic anemia (HP:0004840) | 1.82966765 |
116 | Acne (HP:0001061) | 1.81008954 |
117 | Hepatosplenomegaly (HP:0001433) | 1.80467965 |
118 | Distal lower limb amyotrophy (HP:0008944) | 1.80429336 |
119 | Persistence of primary teeth (HP:0006335) | 1.79450372 |
120 | Optic neuritis (HP:0100653) | 1.79416821 |
121 | Retrobulbar optic neuritis (HP:0100654) | 1.79416821 |
122 | Abnormality of T cell physiology (HP:0011840) | 1.79326523 |
123 | Aortic dissection (HP:0002647) | 1.79231909 |
124 | Abnormality of oral frenula (HP:0000190) | 1.78898302 |
125 | Gastrointestinal stroma tumor (HP:0100723) | 1.78770784 |
126 | Pulmonary embolism (HP:0002204) | 1.76930855 |
127 | Abnormality of eosinophils (HP:0001879) | 1.75602554 |
128 | Hand muscle atrophy (HP:0009130) | 1.75411120 |
129 | Premature rupture of membranes (HP:0001788) | 1.75315097 |
130 | Vertebral arch anomaly (HP:0008438) | 1.75258758 |
131 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.74520764 |
132 | Prolonged bleeding time (HP:0003010) | 1.74182023 |
133 | Stomatitis (HP:0010280) | 1.72579019 |
134 | Cervical subluxation (HP:0003308) | 1.71985856 |
135 | Abnormality of the peritoneum (HP:0002585) | 1.71875035 |
136 | Osteomyelitis (HP:0002754) | 1.71308731 |
137 | Hypergammaglobulinemia (HP:0010702) | 1.71024453 |
138 | Granulocytopenia (HP:0001913) | 1.70832165 |
139 | Pointed chin (HP:0000307) | 1.70818333 |
140 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.69400334 |
141 | Dislocated radial head (HP:0003083) | 1.67883325 |
142 | Vertebral compression fractures (HP:0002953) | 1.66508988 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.04079217 |
2 | PRPF4B | 3.48680606 |
3 | TRIB3 | 3.03820594 |
4 | MAP3K13 | 2.62506525 |
5 | MAP3K10 | 2.58723968 |
6 | EEF2K | 2.54571644 |
7 | ERN1 | 2.48628016 |
8 | JAK3 | 2.37044799 |
9 | SIK2 | 2.20622388 |
10 | TYK2 | 2.16253719 |
11 | RIPK4 | 2.11997020 |
12 | GRK6 | 2.11519077 |
13 | MAP3K14 | 2.10835885 |
14 | CDK12 | 2.10188816 |
15 | PKN2 | 2.04236785 |
16 | TTN | 2.00241409 |
17 | JAK1 | 1.85658331 |
18 | TBK1 | 1.84321271 |
19 | MAP3K11 | 1.82871222 |
20 | STK10 | 1.78658104 |
21 | ZAP70 | 1.73783951 |
22 | KIT | 1.63497109 |
23 | HCK | 1.56490482 |
24 | MAP3K3 | 1.55463661 |
25 | SMG1 | 1.46782869 |
26 | LRRK2 | 1.44567829 |
27 | IKBKB | 1.41656189 |
28 | TXK | 1.40669193 |
29 | CSF1R | 1.39862765 |
30 | TAOK2 | 1.37061851 |
31 | SYK | 1.36996252 |
32 | IKBKE | 1.36390987 |
33 | BLK | 1.33713275 |
34 | TAOK1 | 1.33527356 |
35 | BTK | 1.30260245 |
36 | RPS6KA4 | 1.29990969 |
37 | MAP3K9 | 1.29832745 |
38 | FES | 1.27623296 |
39 | EPHB1 | 1.21931267 |
40 | CSK | 1.19873855 |
41 | MAP3K1 | 1.19663796 |
42 | CHUK | 1.18660554 |
43 | ITK | 1.17221269 |
44 | PTK6 | 1.14035423 |
45 | IRAK3 | 1.09715951 |
46 | FGFR4 | 1.07237859 |
47 | BMX | 1.07086213 |
48 | ALK | 1.04675531 |
49 | CDC42BPA | 1.01966885 |
50 | LCK | 1.00606510 |
51 | IRAK4 | 0.99737568 |
52 | FLT3 | 0.99489795 |
53 | CLK1 | 0.98891105 |
54 | TESK2 | 0.98309074 |
55 | RIPK1 | 0.96910429 |
56 | TESK1 | 0.94990803 |
57 | FGFR3 | 0.94807143 |
58 | SCYL2 | 0.94567153 |
59 | DMPK | 0.92219145 |
60 | KSR2 | 0.91490912 |
61 | MAP3K7 | 0.88525057 |
62 | PRKCH | 0.88504841 |
63 | MAP2K3 | 0.87592529 |
64 | PDPK1 | 0.87366227 |
65 | STK38 | 0.84927177 |
66 | MARK2 | 0.84308565 |
67 | PIM1 | 0.81002867 |
68 | CAMKK1 | 0.77102620 |
69 | MAP3K6 | 0.77071637 |
70 | MAPK12 | 0.76903534 |
71 | SIK3 | 0.75787369 |
72 | ICK | 0.75511340 |
73 | PRKD2 | 0.73668680 |
74 | MAPK11 | 0.73022053 |
75 | MARK3 | 0.72955966 |
76 | RET | 0.70615525 |
77 | PTK2B | 0.69609250 |
78 | NEK2 | 0.67560866 |
79 | PTK2 | 0.67428784 |
80 | JAK2 | 0.67194637 |
81 | RPS6KL1 | 0.66351872 |
82 | RPS6KC1 | 0.66351872 |
83 | PAK4 | 0.64435361 |
84 | TRPM7 | 0.63628101 |
85 | MAPK7 | 0.63609899 |
86 | CAMK1G | 0.63285089 |
87 | RPS6KA2 | 0.62808524 |
88 | PIK3CG | 0.61281783 |
89 | CDK6 | 0.59453760 |
90 | CAMK1D | 0.59151318 |
91 | PDGFRA | 0.58345459 |
92 | TNK2 | 0.58081415 |
93 | IRAK1 | 0.57910480 |
94 | PDGFRB | 0.57558977 |
95 | CDK4 | 0.57317701 |
96 | GRK7 | 0.57310979 |
97 | DAPK1 | 0.55877829 |
98 | SIK1 | 0.55573550 |
99 | TEC | 0.55476209 |
100 | PDK1 | 0.54985611 |
101 | MAP3K8 | 0.54626736 |
102 | EPHA3 | 0.52717028 |
103 | RAF1 | 0.52499581 |
104 | DYRK1B | 0.52162938 |
105 | TYRO3 | 0.51228168 |
106 | NLK | 0.50056614 |
107 | MTOR | 0.49981533 |
108 | PRKCQ | 0.49335093 |
109 | IRAK2 | 0.48975091 |
110 | LYN | 0.48972721 |
111 | PRKD3 | 0.48750194 |
112 | FGR | 0.45715635 |
113 | KDR | 0.44778345 |
114 | TAOK3 | 0.44359453 |
115 | MOS | 0.43143927 |
116 | HIPK2 | 0.42106583 |
117 | TGFBR2 | 0.41886175 |
118 | YES1 | 0.41508810 |
119 | MAPKAPK2 | 0.41350178 |
120 | STK11 | 0.40042316 |
121 | MAPK4 | 0.39774568 |
122 | SGK3 | 0.38542123 |
123 | FYN | 0.37913499 |
124 | RPS6KA6 | 0.37196647 |
125 | BRD4 | 0.36546468 |
126 | MATK | 0.36085417 |
Rank | Gene Set | Z-score |
---|---|---|
1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25425718 |
2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.20882369 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.03348555 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.02299777 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.95179034 |
6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.92345142 |
7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.90294607 |
8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.77631105 |
9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.75537380 |
10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.74434027 |
11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.71043028 |
12 | Measles_Homo sapiens_hsa05162 | 1.63693397 |
13 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.63019564 |
14 | Shigellosis_Homo sapiens_hsa05131 | 1.61270895 |
15 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.54717096 |
16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54384333 |
17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45290697 |
18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43406690 |
19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43172595 |
20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42325771 |
21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.41565368 |
22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.40285553 |
23 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.38640255 |
24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33714626 |
25 | Asthma_Homo sapiens_hsa05310 | 1.33398735 |
26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30972300 |
27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.30623867 |
28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.27921332 |
29 | Tuberculosis_Homo sapiens_hsa05152 | 1.26718371 |
30 | Apoptosis_Homo sapiens_hsa04210 | 1.26573918 |
31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25042206 |
32 | Hepatitis B_Homo sapiens_hsa05161 | 1.25007703 |
33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.24690002 |
34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.23712672 |
35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.23356269 |
36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.23152698 |
37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.22521045 |
38 | Platelet activation_Homo sapiens_hsa04611 | 1.20825541 |
39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18485909 |
40 | Influenza A_Homo sapiens_hsa05164 | 1.13548254 |
41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.13004966 |
42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12054311 |
43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11469268 |
44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09850254 |
45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.08889021 |
46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08399971 |
47 | Glioma_Homo sapiens_hsa05214 | 1.08109892 |
48 | Allograft rejection_Homo sapiens_hsa05330 | 1.04673714 |
49 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03396788 |
50 | Phagosome_Homo sapiens_hsa04145 | 1.03098564 |
51 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.00795736 |
52 | Salmonella infection_Homo sapiens_hsa05132 | 1.00575323 |
53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00069290 |
54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.99288919 |
55 | Colorectal cancer_Homo sapiens_hsa05210 | 0.95547185 |
56 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.95542536 |
57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.93668138 |
58 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.91573776 |
59 | Pertussis_Homo sapiens_hsa05133 | 0.90901382 |
60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89626268 |
61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86333342 |
62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85704760 |
63 | Focal adhesion_Homo sapiens_hsa04510 | 0.81972350 |
64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.81850521 |
65 | Endocytosis_Homo sapiens_hsa04144 | 0.80921548 |
66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.80747653 |
67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.79878961 |
68 | Malaria_Homo sapiens_hsa05144 | 0.79672076 |
69 | Legionellosis_Homo sapiens_hsa05134 | 0.78478823 |
70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78233017 |
71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77092549 |
72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76851627 |
73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76739652 |
74 | Adherens junction_Homo sapiens_hsa04520 | 0.76413495 |
75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.75500209 |
76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75254588 |
77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75246648 |
78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75118550 |
79 | Amoebiasis_Homo sapiens_hsa05146 | 0.74909013 |
80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74479096 |
81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73717168 |
82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70387496 |
83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69707257 |
84 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67752583 |
85 | Hepatitis C_Homo sapiens_hsa05160 | 0.67716032 |
86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67523196 |
87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67483814 |
88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66943967 |
89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66943673 |
90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66634766 |
91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66536606 |
92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65427661 |
93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.64462227 |
94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63933554 |
95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63306947 |
96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63237447 |
97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62488288 |
98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61665320 |
99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61450173 |
100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61298485 |
101 | Insulin resistance_Homo sapiens_hsa04931 | 0.61144722 |
102 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60505383 |
103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60493801 |
104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60209651 |
105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58776867 |
106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58742142 |
107 | Lysosome_Homo sapiens_hsa04142 | 0.57373498 |
108 | Bladder cancer_Homo sapiens_hsa05219 | 0.56815851 |
109 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56507725 |
110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56055673 |
111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56015785 |
112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55071331 |
113 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.54443222 |
114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54387413 |
115 | Prostate cancer_Homo sapiens_hsa05215 | 0.52829421 |
116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52034548 |
117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48040313 |